The Legal News

One of the largest drug makers in the world,  Sanofi-Aventi, retracted its application for Zimulti weight loss drug here in the states. The FDA voted that Zimulta not be approved because it generates suicidal thoughts.

The pill had a live date of July 26, but the withdrawl of the application was due to there not being enough time to fix the drug. Sanofi-Aventis claims they are dedicated to getting the FDA approval, and will meet with the agency to find out what they need to do to make it right.

FDA shows that the individuals who took 1 pill a day showed significant weight loss. ZImulti with a proper diet had people losing 5% more than just dieting.

The FDA was against the drug because during the trial period 3 people killed themselves. There was an unconfirmed 4th suicide. Studies show that side effects include depression, suicide, and anxiety.

Hey, if you are gonna be depressed and upset,  cheaper to just be fat.